Literature DB >> 32918499

Reactive infectious mucocutaneous eruption: Mycoplasma pneumoniae-induced rash and mucositis and other parainfectious eruptions.

M L Ramien1,2.   

Abstract

Mycoplasma pneumoniae-induced rash and mucositis is the most accurate diagnosis for patients with blistering mucocutaneous disease provoked by an infection. Recent literature suggests expansion of the name is required, as other infections have caused a clinically similar presentation. This review provides a concise update on current understanding of M. pneumoniae-induced rash and mucositis and other reactive infectious mucocutaneous eruptions.
© 2020 British Association of Dermatologists.

Entities:  

Year:  2020        PMID: 32918499     DOI: 10.1111/ced.14404

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  5 in total

Review 1.  [Viral exanthems in children].

Authors:  Julia E Fromme; Iliana Tantcheva-Poór; Regina Fölster-Holst
Journal:  Hautarzt       Date:  2022-05-25       Impact factor: 1.198

2.  Baicalin relieves Mycoplasma pneumoniae infection‑induced lung injury through regulating microRNA‑221 to inhibit the TLR4/NF‑κB signaling pathway.

Authors:  Han Zhang; Xiang Li; Juan Wang; Qi Cheng; Yunxiao Shang; Guizhen Wang
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

3.  Mycoplasma pneumoniae-Induced Rash and Mucositis (MIRM) Mimicking Behçet's Disease and Paraneoplastic Pemphigus (PNP).

Authors:  Hanish Jain; Garima Singh; Timothy Endy
Journal:  Case Rep Infect Dis       Date:  2022-08-22

4.  Reactive infectious mucocutaneous eruption - repeat etanercept after intravenous immunoglobulin: A case report.

Authors:  Rochelle Tonkin; Malika Ladha; Nicole Johnson; William F Astle; Ami Britton; Neil H Shear; Luis Murguía-Favela; Michele Ramien
Journal:  SAGE Open Med Case Rep       Date:  2022-08-17

5.  Reactive infectious mucocutaneous eruption following COVID-19 in an adolescent boy: Case report and review of the literature.

Authors:  Ayisha Mahama; Priscilla Kojder; Quinn Thibodeaux; Jennifer Ruth
Journal:  Pediatr Dermatol       Date:  2022-08-30       Impact factor: 1.997

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.